New Medicare GLP-1 Bridge Program: Are You Eligible for the July 1 Launch?

If you are a Medicare beneficiary looking for access to chronic weight management medications, an important temporary program is launching soon to help bridge the current coverage gap.

Beginning July 1, 2026, the Centers for Medicare & Medicaid Services (CMS) is introducing the Medicare GLP-1 Bridge program. Running through December 31, 2027, this short-term demonstration allows eligible Part D beneficiaries to access specific weight-loss medications for a flat $50 copay per monthly supply.

image

For a full, comprehensive breakdown of the program’s rules, clinical requirements, and cost structures, Please visit our dedicated Website page: [Here]


Do You Qualify?

The program is entirely provider-driven, and eligibility is based on your physical metrics at the time you first initiated GLP-1 therapy (even if you started taking the medication before this program launches or before you enrolled in Medicare).

To be eligible, you must be at least 18 years old, actively enrolled in a standalone Medicare Prescription Drug Plan (PDP) or a Medicare Advantage plan with drug coverage (MA-PD), and meet one of the following baseline Body Mass Index (BMI) thresholds:

  • BMI of 35 or greater: Automatically qualifies with no secondary medical conditions required.

  • BMI of 30 or greater: Requires a documented diagnosis of heart failure (including heart failure with preserved ejection fraction / HFpEF), uncontrolled hypertension (high blood pressure), or kidney disease.

  • BMI of 27 or greater: Requires a documented diagnosis of pre-diabetes (per American Diabetes Association guidelines), a previous heart attack (myocardial infarction), a previous stroke, or peripheral artery disease (PAD).
  • Clinical Supervision: Requires ongoing provider monitoring to track kidney function, blood sugar, and potential safety risks like rapid muscle loss.


Covered Medications & Formulations:

The program is limited to medications prescribed soley for chronic weight management. Covered options include Wegovy®, a pill form called Foundayo®, and Zepbound®.

Note: Only the KwikPen® formulation of Zepbound is coverable under this program. Single-dose vials and single-dose pens are completely excluded.

image

Understanding the Cost Rules:

While the flat $50 monthly copay offers immediate savings, it comes with a major structural catch:

  • Because this program operates entirely outside the normal Medicare Part D framework, your $50 copays do not count toward your Part D deductible, Gross Covered Prescription Drug Costs (GCPDC), or True Out-of-Pocket (TrOOP) limits.
  • The copay remains identical regardless of your standard plan's coverage phase, meaning it provides no financial progress toward hitting your standard plan’s $0 out-of-pocket cap.

Important Disqualifications:

By law, if you have a medical condition that allows a GLP-1 to be covered under standard Part D, you are disqualified from the Bridge program and must use your Part D coverage. This includes having Type 2 Diabetes (which routes coverage through Part D, typically using Mounjaro®) or certain Established Cardiovascular Diseases if your specific weight-loss drug is FDA-approved to reduce major adverse cardiovascular risks.

Note: Being routed through standard Part D is generally more financially advantageous in the long run, as those costs count toward your TrOOP cap, leading to $0 copays once the cap is hit.

How to Access the Program:


The program runs from July 1, 2026, through December 31, 2027. You do not need to fill out an application. To get started:

  1. Talk to your doctor to see if a covered GLP-1 medication is medically right for you.

  2. Your doctor submits a formal prior authorization (PA) request directly to the program's designated central processing center, confirming your qualifying metrics and clinical need.

  3. The central processing center reviews and adjudicates the PA request. Once approved, notification is pushed through the pharmacy network.
  4. You fill the prescription at your regular pharmacy. Once approved, the notification is pushed through the pharmacy network. You fill your prescription at your usual pharmacy for the flat $50 copay. Subsequent refills do not require a new approval unless your doctor switches you to a different covered GLP-1 drug.


image

For a full, comprehensive breakdown of the program’s rules, clinical requirements, and cost structures, Please visit our dedicated Website page: [Here]


image

If you have any questions regarding Medicare's new GLP-1 Bridge program, or had any other questions come up while reading, please dont hesitate to reach out to us! We are always happy to help. Just reply to this email, or Call us at 720-259-4777.

Featured Blogs